ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02144051
Brief Title: Phase I Open Label Dose Escalation Study to Investigate the Safety & Pharmacokinetics of AZD5312 in Patients With Androgen Receptor Tumors

First Submitted : April 29, 2014
First Submitted that Met QC Criteria : May 19, 2014
First Posted : May 21, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : July 13, 2016
Last Update Posted : July 14, 2016 (Estimate)